Clinical Trials Logo

Acute Kidney Failure clinical trials

View clinical trials related to Acute Kidney Failure.

Filter by:

NCT ID: NCT03846258 Withdrawn - Acute Kidney Injury Clinical Trials

High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy

Start date: May 1, 2019
Phase: Phase 4
Study type: Interventional

Researchers are trying to determine which dialysis solution, low bicarbonate fluid (22 mmol/L) or high bicarbonate fluid (32 mmol/L), is better in subjects with acute kidney injury (acute kidney failure) and metabolic acidosis that are admitted to the intensive care unit and require continuous renal replacement therapy (also known as continuous dialysis).

NCT ID: NCT03836742 Completed - Acute Kidney Injury Clinical Trials

HEmoFiltration With Citric Acid Anticoagulation

HEFCAA
Start date: August 11, 2015
Phase:
Study type: Observational

Prospective observational study of all consecutive cardio-vascular surgical patients treated with post-dilution hemofiltration with regional citrate anticoagulation as first-choice anticoagulation method. The filter life-span was assessed in the context of postoperative cardiac surgical antithrombotic prophylaxis. Reasons for termination of hemofiltration sessions were assessed. The second aim of this study was to assess the influence ACD-A based anticoagulation protocol on acid-base and ion homeostasis in cardiac surgical patients with acute renal failure.

NCT ID: NCT03675906 Active, not recruiting - Clinical trials for Acute Kidney Failure

The Relationship Between Hypoalbuminemia and Development of Acute Kidney Failure (AKI) According to KDIGO Criteria

Start date: September 12, 2018
Phase:
Study type: Observational

This study was designed to determine the association between preoperative and postoperative hypoalbuminemia and AKI in older age hip fracture surgeons, to determine which period of hypoalbuminemia contributes more to AKI development, the incidence of AKI according to anesthesia type, the presence of other factors affecting AKI development, the duration of hospitalization and cost- to be investigated.

NCT ID: NCT03655561 Recruiting - Acute Kidney Injury Clinical Trials

Lassa Fever Clinical Course and Prognostic Factors in Nigeria

LASCOPE
Start date: April 5, 2018
Phase:
Study type: Observational [Patient Registry]

The investigators propose to conduct a nationwide (Nigeria), prospective, non-interventional cohort study describing the clinical course, biological characteristics, case management and outcomes in patients hospitalized for a suspected or confirmed diagnosis of Lassa fever in tertiary medical facilities situated in the most affected Nigerian states. Special focuses will be made on situations at risk of bad outcome such as pregnancies, acute kidney injury and electrolytic imbalance in patients with confirmed Lassa fever. Participants for which the diagnosis of Lassa fever will be finally excluded by reverse-transcriptase polymerase chain reaction (RT-PCR) will constitute the control group.

NCT ID: NCT02991742 Not yet recruiting - Clinical trials for Acute Kidney Failure

Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients (IDPC Trial)

IDPC
Start date: December 2016
Phase: N/A
Study type: Observational

Contrast media-induced nephropathy following diagnostic and therapeutic cardiac catheterization.

NCT ID: NCT02486614 Completed - Clinical trials for Acute Kidney Failure

Effect of Citrate on the Coagulation System in Patients Receiving CRRT

Citroco
Start date: June 2014
Phase:
Study type: Observational

The aim of this study is to evaluate the effect of regional citrate anti-coagulation on different pathways of the coagulation system in critically ill patients with acute kidney injury. This will form the basis for future studies where the investigators plan to focus on patients with premature circuit clotting despite optimal post-filtrate ionised calcium parameters.

NCT ID: NCT02470520 Completed - Clinical trials for Acute Kidney Failure

Essential Nutrients in Critically Ill Patients With Severe AKI Treated With and Without CRRT

Start date: August 2013
Phase: N/A
Study type: Observational

The aim of this study is to measure plasma levels of essential vitamins, trace elements and amino acids in critically ill patients with severe AKI. In patients who are treated with continuous renal replacement therapy, we plan to evaluate whether there are any additional losses of nutrients into the filtrate.

NCT ID: NCT02470507 Active, not recruiting - Clinical trials for Acute Kidney Failure

Immune Function in Acute Kidney Injury

Start date: June 2013
Phase:
Study type: Observational

The immune response to kidney damage during acute kidney injury (AKI) is an important contributor to the prolonged lack of renal function and progression of kidney injury. Most data related to intrarenal and interorgan pathways in AKI stem from animal research with sometimes conflicting results. Accurate evaluation of these processes in humans and identification of early diagnostic tools are critical for the development of strategies to prevent and attenuate AKI-related morbidity and mortality in patients. The aim of this study is to evaluate immune function and miRNA expression in hospitalised patients with and without AKI.

NCT ID: NCT02159209 Completed - Acute Kidney Injury Clinical Trials

The Drug Induced Renal Injury Consortium

DIRECT
Start date: February 2013
Phase: N/A
Study type: Observational

Some medications are known to cause kidney damage because the person is allergic to the medication while others cause direct damage to the kidney because they are toxic at certain concentrations. Risk factors for developing kidney damage have been identified for some medications but not for all. Patients who are exposed to these important medications and develop problems with their kidneys may have some genetic risk. The purpose of this study is to determine the genetic risk factors for drug induced kidney injury. A better understanding of the role of genetics for the development of kidney injury from medications will allow us to better select medications, improve effectiveness of treatment and minimize harm.

NCT ID: NCT01544231 Completed - Clinical trials for Acute Kidney Failure

Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis

Start date: August 2013
Phase: N/A
Study type: Observational

This research project consists of a prospective diagnostic study conducted on patients with clinical suspicion of rhabdomyolysis admitted to the emergency rooms of the University Hospitals of Nimes, Montpellier, Paris, Nice and Toulon Inter Army Hospital. The main objective of this study is to determine whether the plasma level of Neutrophil Gelatinase Associated Lipocalin (NGAL) may be retained as a predictor of acute renal failure (ARF) occurring within 48 hours after admission for rhabdomyolysis.